Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer

Clinical trial NCT01409005 · COMPLETED

Trial details

NCT number: NCT01409005
Sponsor: Seoul National University Bundang Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic or Recurrent Colorectal Cancer Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan Salvage Chemotherapy

Start date: 2011-06-01
Primary completion: 2013-02-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.